Literature DB >> 19587449

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence.

Barbara Rehermann1.   

Abstract

Since the identification of the hepatitis C virus (HCV) 20 years ago, much progress has been made in our understanding of its life cycle and interaction with the host immune system. Much has been learned from HCV itself, which, via decades of coevolution, gained an intricate knowledge of host innate and adaptive immune responses and developed sophisticated ways to preempt, subvert, and antagonize them. This review discusses the clinical, virological, and immunological features of acute and chronic hepatitis C and the role of the immune response in spontaneous and treatment-induced HCV clearance.

Entities:  

Mesh:

Year:  2009        PMID: 19587449      PMCID: PMC2701885          DOI: 10.1172/JCI39133

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  124 in total

1.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

2.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

3.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

4.  Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production.

Authors:  Harel Dahari; Marian Major; Xinan Zhang; Kathleen Mihalik; Charles M Rice; Alan S Perelson; Stephen M Feinstone; Avidan U Neumann
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

Review 5.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

7.  New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.

Authors:  Deborah R Taylor; Montserrat Puig; Miriam E R Darnell; Kathleen Mihalik; Stephen M Feinstone
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.

Authors:  Stuart C Ray; Liam Fanning; Xiao-Hong Wang; Dale M Netski; Elizabeth Kenny-Walsh; David L Thomas
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

10.  Cellular immune selection with hepatitis C virus persistence in humans.

Authors:  Andrea L Cox; Timothy Mosbruger; Qing Mao; Zhi Liu; Xiao-Hong Wang; Hung-Chih Yang; John Sidney; Alessandro Sette; Drew Pardoll; David L Thomas; Stuart C Ray
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

View more
  243 in total

Review 1.  Induction and evasion of innate antiviral responses by hepatitis C virus.

Authors:  Stanley M Lemon
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Authors:  Joo Chun Yoon; Jong-Baeck Lim; Jeon Han Park; Jae Myun Lee
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Plasmacytoid dendritic cells as guardians in hepatitis C virus-infected liver.

Authors:  Selena M Sagan; Peter Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 4.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

5.  Differential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.

Authors:  Jia M Wang; Lei Shi; Cheng J Ma; Xiao J Ji; Ruo S Ying; Xiao Y Wu; Ke S Wang; Guangyu Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

6.  Role of genetic polymorphisms in hepatitis C virus chronic infection.

Authors:  Nicola Coppola; Mariantonietta Pisaturo; Caterina Sagnelli; Lorenzo Onorato; Evangelista Sagnelli
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

7.  Dendritic cell co-stimulatory and co-inhibitory markers in chronic HCV: an Egyptian study.

Authors:  Hanan Fouad; Maissa Saeed El Raziky; Rasha Ahmed Abdel Aziz; Dina Sabry; Ghada Mahmoud Abdel Aziz; Manal Ewais; Ahmed Reda Sayed
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 8.  Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.

Authors:  Lynn B Dustin; Edgar D Charles
Journal:  Antivir Ther       Date:  2012-12-07

9.  Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

Authors:  Moutaz Derbala; Nasser Rizk; Fatima Shebl; Saad Alkaabi; Nazeeh Eldweik; Anil John; Manik Sharma; Rafie Yaqoob; Muneera Almohanadi; Mohammed Butt; Khaled Alejji
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 10.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.